GoldenGolden
Advanced Search
Thirty Madison

Thirty Madison

A full-service healthcare company in New York that focuses on providing medications.

Thirty Madison is a full-service healthcare company in New York that focuses on providing medications. Founded 2017 in New York, United States by Demetri Karagas and Steven Gutentag, Thirty Madison has raised a total of $22.8M in funding over two rounds. Their latest funding was raised on October 16, 2018 from a Series A round. Thirty Madison is funded by 8 investors. As of March 2020, Steadfast Venture Capital and Greycroft are the most recent investors. Thirty Madison combines virtual diagnosis and FDA-approved treatments to create access to preventative medicine and care for men experiencing hair loss.

Timeline

August 17, 2020
Thirty Madison raises $47 million in a series B funding round led by healthcare venture capital firm Polaris Partners. Johnson & Johnson's innovation arm, Johnson & Johnson Innovation – JJDC, Inc., joined the round as a new investor. Existing investors Maveron and Northzone also participated in that round.
August 14, 2020
Thirty Madison raises a $47,000,000 series B round.
October 16, 2018
Thirty Madison raises a $15,250,000 series A round from Maveron.
October 2018
Thirty Madison raises a $15,250,000 series A round from ERA, First Round Capital, Greycroft, Maveron, Northzone, Steadfast Venture Capital and Two River Ventures.
2017
Founded

Funding rounds

People

Name
Role
LinkedIn

Demetri Karagas

Founder

Steven Gutentag

Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Pharmacy Times®
June 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Pharmacy Times® has expanded its Strategic Alliance Partnership (SAP) program with the addition of Thirty Madison. The "human-first" health...
FinSMEs
June 5, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Blake Dodge
June 4, 2021
Business Insider
Thirty Madison hit a more than $1 billion valuation in June. Here's how the healthcare startup won over investors in 2020.
Heather Landi
June 2, 2021
FierceHealthcare
Four years after launching, fast-growing digital health company Thirty Madison has vaulted to unicorn status. The New York City-based startup, which offers direct-to-consumer telehealth visits and online prescriptions for drugs for hair loss, migraines and acid reflux, banked $140 million in a Series C round that now values the company at $1 billion.
AlleyWatch
December 1, 2020
AlleyWatch
The Pulse of New York Tech
Heather Landi
August 17, 2020
FierceHealthcare
Johnson & Johnson is investing in direct-to-consumer telehealth company Thirty Madison. The New York City-based startup offers telehealth visits and online prescriptions for drugs for hair loss, migraines and acid reflux. Here's why the pharmaceutical giant is backing the telehealth company.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.